Multivalent Tryptophan- and Tyrosine-Containing [60]Fullerene Hexa-Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
21 Jul 2021
Historique:
received: 26 03 2021
pubmed: 15 4 2021
medline: 24 7 2021
entrez: 14 4 2021
Statut: ppublish

Résumé

Unprecedented 3D hexa-adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and EV71 reveal that they are much more potent against HIV and equally active against EV71 than the previously described dendrimer prototypes AL-385 and AL-463, which possess the same number of Trp/Tyr residues on the periphery but attached to a smaller and more flexible pentaerythritol core. These results demonstrate the relevance of the globular 3D presentation of the peripheral groups (Trp/Tyr) as well as the length of the spacer connecting them to the central core to interact with the viral envelopes, particularly in the case of HIV, and support the hypothesis that [60]fullerene can be an alternative and attractive biocompatible carbon-based scaffold for this type of highly symmetrical dendrimers. In addition, the functionalized fullerenes here described, which display twelve peripheral negatively charged indole moieties on their globular surface, define a new and versatile class of compounds with a promising potential in biomedical applications.

Identifiants

pubmed: 33851758
doi: 10.1002/chem.202101098
pmc: PMC8361981
doi:

Substances chimiques

Fullerenes 0
Tyrosine 42HK56048U
Tryptophan 8DUH1N11BX
Hexosaminidase A EC 3.2.1.52

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10700-10710

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : CTQ2017-84327-P
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : CTQ2017-83531-R
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : Projects PID2019-104070RB-C21 and PID2019-104070RB-C22
Organisme : Consejo Superior de Investigaciones Científicas
ID : CSIC, Projects CSIC-PIE-201980E100 and CSIC-PIE-201980E028

Informations de copyright

© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Références

Org Biomol Chem. 2015 Aug 28;13(32):8750-5
pubmed: 26186577
Eur J Med Chem. 2003 Nov-Dec;38(11-12):913-23
pubmed: 14642323
Chem Commun (Camb). 2010 Jun 14;46(22):3860-2
pubmed: 20414495
Antiviral Res. 2013 May;98(2):158-70
pubmed: 23541872
Adv Exp Med Biol. 2012;726:223-42
pubmed: 22297516
Org Biomol Chem. 2007 Nov 21;5(22):3599-613
pubmed: 17971989
Phys Chem Chem Phys. 2011 Apr 14;13(14):6517-30
pubmed: 21369604
Antiviral Res. 2017 Mar;139:32-40
pubmed: 28017762
Nat Med. 2009 Jul;15(7):798-801
pubmed: 19543282
Drugs. 2020 Sep;80(14):1485-1490
pubmed: 32852743
Curr Top Med Chem. 2016;16(10):1074-90
pubmed: 26324044
J Biol Chem. 2011 Jan 14;286(2):1588-97
pubmed: 20961847
J Nippon Med Sch. 2012;79(4):248-54
pubmed: 22976602
Drug Des Devel Ther. 2015 Oct 01;9:5447-68
pubmed: 26491256
J Am Chem Soc. 2011 Oct 26;133(42):16758-61
pubmed: 21916422
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5731-41
pubmed: 27431232
Chemistry. 2016 Sep 5;22(37):13147-55
pubmed: 27516128
J Enzyme Inhib Med Chem. 2016;31(sup1):164-176
pubmed: 27168130
J Med Chem. 2020 Jan 9;63(1):349-368
pubmed: 31809045
Org Biomol Chem. 2015 Jan 7;13(1):25-54
pubmed: 25329994
Biomacromolecules. 2013 Feb 11;14(2):431-7
pubmed: 23281578
Drugs. 2018 Mar;78(4):505-511
pubmed: 29464664
Chemistry. 2018 Sep 20;24(53):14088-14100
pubmed: 30058727
Chemistry. 2013 Dec 2;19(49):16791-803
pubmed: 24150869
Chem Asian J. 2014 Jun;9(6):1436-44
pubmed: 24678063
Org Lett. 2006 Nov 23;8(24):5641-3
pubmed: 17107092
RSC Adv. 2018;8(73):41692-41698
pubmed: 31543960
Nanomedicine (Lond). 2018 Dec;13(23):2981-2993
pubmed: 30501557
Antimicrob Agents Chemother. 2014 Nov;58(11):6990-2
pubmed: 25199773
Antimicrob Agents Chemother. 1993 Feb;37(2):332-8
pubmed: 8452366
Curr Pharm Des. 2013;19(10):1784-99
pubmed: 23092280
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3226-9
pubmed: 26081290
Int J Nanomedicine. 2007;2(4):639-49
pubmed: 18203430
Cell Microbiol. 2012 Aug;14(8):1183-92
pubmed: 22583677
J Am Chem Soc. 2019 Sep 25;141(38):15403-15412
pubmed: 31469952
Chem Commun (Camb). 2011 Jan 28;47(4):1321-3
pubmed: 21103505
AIDS. 2019 Jan 27;33(1):1-11
pubmed: 30096076
J Virol. 2007 Jan;81(1):362-73
pubmed: 17050611
J Mater Chem B. 2017 Aug 28;5(32):6546-6556
pubmed: 32264416
Lancet. 2003 May 10;361(9369):1577-8
pubmed: 12747873
Chemistry. 2021 Jul 21;27(41):10700-10710
pubmed: 33851758
Chem Commun (Camb). 2011 Aug 7;47(29):8298-300
pubmed: 21666897
Org Biomol Chem. 2015 Jun 21;13(23):6482-92
pubmed: 25967393
Chemistry. 2018 Feb 16;24(10):2483-2492
pubmed: 29281149
Antimicrob Agents Chemother. 1992 Jan;36(1):100-7
pubmed: 1317142
J Mater Chem B. 2020 May 27;8(20):4505-4515
pubmed: 32369088
Chemistry. 2011 Jan 17;17(3):766-9
pubmed: 21226088
Bioorg Med Chem. 1996 Jun;4(6):767-79
pubmed: 8818226
Chemistry. 2009 Jul 27;15(30):7423-33
pubmed: 19551779
ACS Nano. 2008 Sep 23;2(9):1950-8
pubmed: 19206436
Protein Cell. 2013 Feb;4(2):86-102
pubmed: 23479426
J Am Chem Soc. 2018 Aug 8;140(31):9891-9898
pubmed: 30014698
J Am Chem Soc. 2017 May 3;139(17):6018-6025
pubmed: 28394600
J Mater Chem B. 2017;5(32):6523-6535
pubmed: 29225883
Eur J Med Chem. 2015 Dec 1;106:34-43
pubmed: 26513643
Expert Opin Ther Pat. 2011 Mar;21(3):399-416
pubmed: 21342055
Nat Chem. 2016 Jan;8(1):50-7
pubmed: 27055288
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4340-4344
pubmed: 29632214
J Org Chem. 2018 Feb 16;83(4):1727-1736
pubmed: 29310437
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5064-7
pubmed: 27246775
PLoS Pathog. 2019 May 9;15(5):e1007760
pubmed: 31071193
Cell Rep. 2016 Mar 22;14(11):2695-706
pubmed: 26972002
Chem Commun (Camb). 2011 Apr 28;47(16):4640-2
pubmed: 21301746
J Mater Chem B. 2017 Aug 28;5(32):6566-6571
pubmed: 32264418
Int J Nanomedicine. 2014;9:77-92
pubmed: 24379667
J Mol Biol. 2020 Feb 14;432(4):1158-1168
pubmed: 31931014

Auteurs

Marta Ruiz-Santaquiteria (M)

Departamento de Química Orgánica, Facultad de Química, Universidad Complutense, 28040, Madrid, Spain.

Beatriz M Illescas (BM)

Departamento de Química Orgánica, Facultad de Química, Universidad Complutense, 28040, Madrid, Spain.

Rana Abdelnabi (R)

Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, University of Leuven, 3000, Leuven, Belgium.

Arnaud Boonen (A)

Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, University of Leuven, 3000, Leuven, Belgium.

Alberto Mills (A)

Departamento de Ciencias Biomédicas y Unidad Asociada IQM-UAH, Universidad de Alcalá, 28805 Alcalá de Henares, Madrid, Spain.

Olaia Martí-Marí (O)

Instituto de Química Médica (IQM-CSIC), IQM-CSIC, 28006, Madrid, Spain.

Sam Noppen (S)

Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, University of Leuven, 3000, Leuven, Belgium.

Johan Neyts (J)

Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, University of Leuven, 3000, Leuven, Belgium.

Dominique Schols (D)

Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, University of Leuven, 3000, Leuven, Belgium.

Federico Gago (F)

Departamento de Ciencias Biomédicas y Unidad Asociada IQM-UAH, Universidad de Alcalá, 28805 Alcalá de Henares, Madrid, Spain.

Ana San-Félix (A)

Instituto de Química Médica (IQM-CSIC), IQM-CSIC, 28006, Madrid, Spain.

María-José Camarasa (MJ)

Instituto de Química Médica (IQM-CSIC), IQM-CSIC, 28006, Madrid, Spain.

Nazario Martín (N)

Departamento de Química Orgánica, Facultad de Química, Universidad Complutense, 28040, Madrid, Spain.
IMDEA-Nanoscience, C/ Faraday 9, Campus de Cantoblanco, 28049, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH